摘要
随着人均寿命的延长和人们对生活质量要求的提高,睾酮作为蛋白同化激素,不但能够改善肌肉和骨骼健康,还能提高精力和性能力,在国外的中老年人群,尤其在迟发型性腺功能减退(LOH)的患者中曾被广泛使用。但随着多个临床研究发现睾酮补充治疗增加心血管疾病等的风险,睾酮的使用直线下降,导致部分需要睾酮治疗的患者得不到及时的治疗。本文综合目前的临床研究结果,就睾酮补充治疗的利弊及所处的困境作一简介。
Due to prolonged life expectancy, people′s requirements for quality of life are also increasing. As a protein anabolic hormone, testosterone not only improves muscle and bone health, but also improves energy and sexual function. It is widely used in middle-aged and elderly people, especially in patients with delayed-onset hypogonadism(LOH). However, as several clinical studies have found that testosterone supplementation increases cardiovascular risk, the use of testosterone decreased sharply, and some patients who require testosterone therapy thus do not receive treatment timely. This article summarizes the current clinical research results and analyzes the dilemma of testosterone supplementation therapy.
作者
刘伟
李圣贤
Liu Wei;Li Shengxian(Department of Endocrinology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200127, China)
出处
《中华内分泌代谢杂志》
CAS
CSCD
北大核心
2019年第2期93-98,共6页
Chinese Journal of Endocrinology and Metabolism
基金
国家自然科学基金(81471029、81270875、81471424).